catalyst health solutions

J.P. Morgan is out with its report today on Catalyst Health Solutions (NASDAQ: CHSI), maintaining Overweight. In a note to clients, J.P. Morgan writes, "This evening, OW-rated Catalyst Health Solutions provided its updated 2011 outlook following the closing of the Walgreens Health Initiatives...

Citi made a number of updates in a research report published today. Solar Capital (NASDAQ: SLRC) has been downgraded from Hold to Buy. At the same time, Citi reduced its price target on the companies stock from $28 to $26. In the report, Citi states, "We are downgrading the shares of SLRC to a...

Citi is initiating coverage of Catalyst Health Solutions, Inc. (NASDAQ: CHSI) at Buy with a $74 PT. Catalyst Health Solutions closed Wednesday at $54.14.

JP Morgan has raised the price target on Catalyst Health Solutions (NASDAQ: CHSI) from $60 to $66 and maintains its Overweight rating.

J.P. Morgan is out with its report today on Catalyst Health Solutions (NASDAQ: CHSI), raising its PT from $53 to $60. In a note to clients, J.P. Morgan writes, "We reiterate our Overweight rating on CHSI. We continue to believe the long term fundamental outlook for CHSI remains strong, based on...

JP Morgan has raised the price target on Catalyst Health Solutions, Inc. (NASDAQ: CHSI) from $53 to $60 and maintains its Overweight rating.

JP Morgan has published a research report on Catalyst Health Solutions (NASDAQ: CHSI) after the company reported 3Q results after market close yesterday. In the report, JP Morgan writes "After the market close, CHSI reported 3Q10 results and provided initial 2011 EPS guidance. Guidance will be the...

Piper Jaffray has published a research report on Catalyst Health Solutions (NASDAQ: CHSI) after the company reported very strong 3Q results that exceeded almost all expectations. In the report, Piper Jaffray writes "Given the confusion in recent months regarding speculation over contract renewals...